AtriCure (ATRC) Tops Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.70 -0.35%
EPS Growth %: +92.3%
Financial Fact:
Net loss: -6.78M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +92.3%
Financial Fact:
Net loss: -6.78M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $70.5 million versus the consensus estimate of $68.68 million.
GUIDANCE:
AtriCure sees FY2021 EPS of ($1.20), versus the consensus of ($1.35). AtriCure sees FY2021 revenue of $270-275 million, versus the consensus of $272 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
